Jeb Keiper, Nimbus CEO
Nimbus clinches $125M raise via big donor-backed private financing round following Bristol Myers' TYK2 approval
More than a year after raising $105 million in a private financing round, Nimbus Therapeutics is back with its next haul as it considers its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
